Hypertension Clinical Trials in Chicago

Showing 121-136 of 136 trials

A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension

NCT00522925

The purpose of the study is to see if PS433540 lowers blood pressure better than placebo and to see how safe PS433540 is compared to placebo.

Hypertension

Ligand Pharmaceuticals280 participantsStarted Aug 2007

Tempe, Arizona, United States • Lincoln, California, United States • Long Beach, California, United States +12 more locations

COMPLETEDPHASE42.2 miles

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

NCT00744237

This study will evaluate the effects of nebivolol on glycemic control compared with metoprolol and HCTZ in patients with hypertension and type 2 diabetes mellitus

HypertensionType 2 Diabetes Mellitus

Forest Laboratories231 participantsStarted Aug 2008

Athens, Alabama, United States • Huntsville, Alabama, United States • Bell Gardens, California, United States +62 more locations

A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

Hypertension Trials in Other Cities

An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan

Secondary Prevention of Small Subcortical Strokes Trial

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension

Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients

One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension

A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure.

Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension

Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension

Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

Other Conditions in Chicago